China · Regulatory rule

China: Science and Technology Ethics Review Measures

Organisations conducting life-science, medical or AI research must establish ethics review arrangements and review projects that raise sensitive ethical issues.

Current status
In force
Published or updated
8 October 2023
Effective date
1 December 2023
Last verified
19 August 2026

Prepared by Longan Bay Area AI Legal Research Center based on official public materials.

01

Scope of application & addressees

  • Universities, research institutions, healthcare bodies and businesses conducting AI research or development
  • AI projects affecting human behaviour, psychology, health, safety or major public interests
  • Teams conducting activities listed as high-risk science and technology ethics work

02

Core regulatory mandates & key requirements

01Qualifying organisations establish an ethics review committee and application, review, re-review and supervision procedures.

02Reviews address necessity, risk and benefit, informed arrangements, fairness, privacy and data security.

03Algorithms with public-opinion or social-mobilisation attributes and highly autonomous safety or health decisions may require expert re-review.

03

Enforcement & compliance timeline

The measures were finalised by the responsible authorities.

The measures were published.

The measures entered into force.

Primary text

Statutory & regulatory text

PROJECT ENQUIRY

Need to evaluate this regulation against your system architecture?

Consult with our regulatory team →